RT Journal Article
SR Electronic
T1 Camrelizumab in combination with apatinib in second-line or above therapy for advanced primary liver cancer: cohort A report in a multicenter phase Ib/II trial
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e002191
DO 10.1136/jitc-2020-002191
VO 9
IS 3
A1 Mei, Kuimin
A1 Qin, Shukui
A1 Chen, Zhendong
A1 Liu, Ying
A1 Wang, Linna
A1 Zou, Jianjun
YR 2021
UL http://jitc.bmj.com/content/9/3/e002191.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.